Jyoti

A+| A| A-|

Profit And Loss

Market
/
Corporate Information
/
Profit And Loss
Easy Menu
Mutual Fund
Corporate Actions
Equity
IPO
Other Markets
Derivatives

Change Company Name

Natco Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

524816

NSE Symbol

NATCOPHARM

P/E

13.18

ISIN Demat

INE987B01026

Div & Yield %

0.54

EPS

83.75

Book Value

461.80

Market Cap (Rs Cr.)

19,771.94

Face Value

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
INCOME :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Sales Turnover	4,094.50	3,568.90	2,351.00	1,767.80	1,653.50	1,790.20
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4,094.50	3,568.90	2,351.00	1,767.80	1,653.50	1,790.20
Other Income	321.30	104.70	85.50	94.60	101.10	123.80
Stock Adjustments	-11.60	-17.20	-34.60	5.50	46.90	55.90
Total Income	4,404.20	3,656.40	2,401.90	1,867.90	1,801.50	1,969.90
EXPENDITURE :	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Raw Materials	581.70	557.30	495.10	540.10	546.90	452.90
Power & Fuel Cost	93.10	88.90	81.90	76.40	59.40	62.40
Employee Cost	515.30	454.90	425.70	410.10	380.00	356.10
Other Manufacturing Expenses	217.70	179.80	150.30	148.70	114.30	134.70
Selling & Administrative Expenses	444.10	483.70	290.70	309.10	140.30	202.30
Miscellaneous Expenses	86.70	150.10	28.00	75.90	41.90	59.70
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1,938.60	1,914.70	1,471.70	1,560.30	1,282.80	1,268.10
Operating Profit	2,465.60	1,741.70	930.20	307.60	518.70	701.80
Interest	19.60	14.50	8.60	13.30	11.30	20.60
Gross Profit	2,446.00	1,727.20	921.60	294.30	507.40	681.20
Depreciation	220.00	171.90	150.90	138.40	115.20	98.10
Profit Before Tax	2,226.00	1,555.30	770.70	155.90	392.20	583.10
Tax	407.50	284.80	133.10	32.50	93.30	129.10
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-31.90	-36.10	0.50	-15.70	-10.60	-20.50
Reported Net Profit	1,850.40	1,306.60	637.10	139.10	309.50	474.50
Extraordinary Items	72.22	-2.12	14.71	33.80	24.39	12.69
Adjusted Net Profit	1,778.18	1,308.72	622.39	105.30	285.11	461.81
Adjustment below Net Profit	3.00	-49.70	-1.00	0.40	2.20	-31.40
P & L Balance brought forward	4,226.30	3,134.60	2,587.10	2,520.50	2,322.50	2,006.80
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	107.50	165.20	88.60	72.90	113.90	127.40
P & L Balance carried down	5,972.20	4,226.30	3,134.60	2,587.10	2,520.30	2,322.50
Dividend	0.00	170.20	100.40	82.10	113.90	127.40
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	300.00	475.00	275.00	225.00	262.50	337.50
Dividend Per Share(Rs)	6.00	9.50	5.50	4.50	5.25	6.75
Earnings Per Share-Unit Curr	103.37	72.99	34.91	7.62	16.96	26.07
Earnings Per Share(Adj)-Unit Curr	103.37	72.99	34.91	7.62	16.96	26.07
Book Value-Unit Curr	409.72	312.42	257.64	229.69	224.17	212.61
Book Value(Adj)-Unit Curr	409.72	312.42	257.64	229.69	224.17	212.61

Profit And Loss

Mutual Fund

Corporate Actions

Equity

IPO

Other Markets

Derivatives

Main Menu

Market